Dr. Chu Chen

For the Media

Dr. Chu Chen

Dr. Chu Chen is a member of Fred Hutch's Public Health Sciences Division. Her research is focused on understanding the molecular epidemiomology of tobacco- and hormone-related cancers and the development of prognostic gene signatures for oral cancer. 

Resources for more information

  • Overview of Chu Chen's Research
    As an epidemiologist, Ceh's research is addressing cancers of the breast, endometrium  lung, prostate, testes and head and neck.
  • Chen Lab
    Investigators in the Chen lab are evaluating of environmental factors, genome-wide data on single nucleotide polymorphisms, heterozygosities, gene copy number alterations, gene expression profiles, and tissue microarray data, we hope to determine the links between environmental and genetic factors and the development of – and/or survival from – tobacco- and hormone-related cancers.
  • Public Health Sciences Division
    Using large populations as our laboratory, our researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.
  • Epidemiology Program
    Fred Hutch's epidemiology program is aimed at understanding the factors that influence the incidence, distribution, and control of cancer and other harmful diseases within the human population.


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


Photos / Graphics / Video


Download photos of Chu Chen

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.